Correlation of<sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Correlation of⁶⁸Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer

Published:2022-05-12 Issue:12 Volume:63 Page:1829-1835
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Duan Heying,Baratto Lucia,Fan Richard E.,Soerensen Simon John Christoph,Liang Tie,Chung Benjamin Inbeh,Thong Alan Eih Chih,Gill Harcharan,Kunder Christian,Stoyanova Tanya,Rusu Mirabela,Loening Andreas M.,Ghanouni Pejman,Davidzon Guido A.,Moradi Farshad,Sonn Geoffrey A.,Iagaru Andrei

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference42 articles.

1. Cancer Statistics, 2021

2. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

3. Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging;Johnson;Eur Urol,2019

4. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

5. Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management;PET Clinics;2024-07

3. 68Ga-RM2 PET–MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial;The Lancet Oncology;2024-04

4. Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer;Annals of Medicine;2024-03-05

5. Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?;Seminars in Nuclear Medicine;2024-01